Ataciguat's Headway in Aortic Stenosis; Baby Pacemakers; AI-ECG Tool for the ED?

(MedPage Today) -- The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the progression of fibrocalcific aortic valve stenosis in phase I and II studies. (Circulation)
The extent of myocardial...